AI in Medicine
Artificial Intelligence has tremendous potential to advance clinical practice and the delivery of patient care.
NEJM AI Grand Rounds Podcast
Hosted by Arjun (Raj) Manrai, Ph.D. and Andrew Beam, Ph.D., NEJM AI Grand Rounds features informal conversations with a variety of unique experts exploring the deep issues at the intersection of artificial intelligence, machine learning, and medicine.
Instead of facilitating communication and transparency, the insertion of LLM-generated text directly into the medical record risks diminishing the quality, efficiency, and humanity of health care.
Large numbers of patients are already using AI tools to obtain medical advice. Rigorous trials of these tools will be important. But what will they be measured against?
More on AI in Medicine
The relational nature of large language models and other forms of generative artificial intelligence raises additional ethical questions for medicine, beyond the daunting ethics surrounding predictive AI.
In this article in the series on artificial intelligence in medicine, the authors explore how human values influence the outputs of large language models and other artificial intelligence models.
The authors address the issues that must be confronted if we are to integrate the use of wearable digital health technologies into clinical care in a way that provides an enduring benefit to patients.
One third of people with epilepsy have seizures despite medical treatment. The authors examine wearable digital health devices that can detect seizures and how these devices can affect epilepsy care.
This article reviews the use of digital wearable technologies for monitoring of three common cardiovascular conditions: hypertension, heart failure, and atrial fibrillation.
Sleep patterns and physical activity can be monitored by wearable technology. The authors describe the state of the art for using data from wearable devices in diagnosing and managing depression.
The authors review challenges arising in malpractice litigation related to software errors to inform health care organizations and physicians about liability risk from AI adoption and about strategies to mitigate risk.
Monitors to measure glucose levels have been paired with software controlling insulin delivery. The authors examine the state of the art in digital technology to manage diabetes (types 1 and 2).
There are various possible futures for regulation of artificial intelligence in the United States. The history of rules governing the treatment of human subjects could hold important insights.
Wearable DHT has reached an inflection point between fanciful descriptions and practical applications. The editors announce a series of articles focusing on the clinical applications of wearable DHT.
Challenges at the interface of medical statistics and AI are population inference vs. prediction, generalizability, reproducibility and interpretation of evidence, and stability and statistical guarantees.
Medical AI tools that are trained on skewed data may exhibit bias. The authors discuss how thinking of clinical data as artifacts can identify values, practices, and patterns of inequity in health care.
The authors, both employed by a company providing consulting services for public and private health care organizations, examine the use of AI in reimbursement, clinical operations, and quality and safety.
Artificial intelligence could have broad implications for medical education. Educators could lead the way when it comes to integrating this technology into clinical practice.
Machine-learning methods for analyzing genomic, transcriptomic, epigenomic, proteomic, and metabolomic data sets have yielded clinically directive information, mostly for rare genetic diseases.
The authors examine the advantages and limitations of current clinical radiologic AI systems, new clinical workflows, and the potential effect of generative AI and large multimodal foundation models.
This article in the AI in Medicine series addresses the use of AI and machine-learning tools to identify and track disease outbreaks and monitor mitigation strategies.
This first article in a series describes the history of artificial intelligence in medicine; the use of AI in image analysis, identification of disease outbreaks, and diagnosis; and the use of chatbots.
The editors announce both a series of articles focusing on AI and machine learning in health care and the 2024 launch of a new journal, NEJM AI, a forum for evidence, resource sharing, and discussion of the possibilities and limitations of medical AI.
Chatbots are computer programs with which one can have a conversation. In this article, the authors describe how the GPT-4 chatbot, which has been given a general education, could affect the practice of medicine.
NEJM AI Event
AI Without Borders: Transforming Global Health Care
April 9, 2025
12:00 PM – 1:15 PM ET





